Skip to content

Analgesic Effect of Ultrasound Guided Maxillary Nerve Block in Trigeminal Neuralgia

Analgesic Effect Evaluation of Ultrasound Guided Maxillary Nerve Block in Trigeminal Neuralgia

Status
Withdrawn
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06129071
Enrollment
0
Registered
2023-11-13
Start date
2023-12-01
Completion date
2025-03-01
Last updated
2024-04-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Trigeminal Neuralgia

Keywords

trigeminal neuralgia, maxillary nerve, ultrasound guided nerve block

Brief summary

This is a study about the dynamics and effects of ultrasound guided maxillary nerve block in trigeminal neuralgia

Detailed description

Standard pharmacological treatment for trigeminal neuralgia is often insufficient. In this setting, patients often suffer trough everyday activities and quality of life is disturbed substantially. In this prospective clinical study, analgesic effect of ultrasound (US) guided maxillary nerve block will be investigated, in order to prolong pain-free time, reduce the use of standard analgesics, as well as atypical ones (e.g. antiepileptic drugs and antidepressants). Characteristics of US guided maxillary nerve block will pain investigated: reduction of pain (decrease of VAS score), duration of pain-free period, pain level during the procedure.

Interventions

PROCEDUREUS guided block of maxillary nerve

Extraoral ultrasound-guided block of the maxillary nerve will be performed in the examined group using an ultrasound device and local anesthetic levobupivacaine (0,5%, 2 mL) combined with triamcinolonacetonid (2mL).

Sponsors

Varazdin General Hospital
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 85 Years
Healthy volunteers
No

Inclusion criteria

* patients with trigeminal neuralgia

Exclusion criteria

* allergy to local anesthetics * local infection at the site of needle puncture * parotitis * serious liver disease * use of antiarrhythmics group III (eg amiodarone) * anticoagulant or antithrombotic drugs * lactation

Design outcomes

Primary

MeasureTime frameDescription
Time without pain26 weeksPatients will report to the investigator when pain starts to rise - and the amount of time form the procedure to the reporting will be recorded

Secondary

MeasureTime frameDescription
Trend of pain levelPain level at three time points: 1 month, 3 months and 6 months after the procedurePain will be graded according to visual analogue scale, 0 meaning no pain, 10 meaning the worse pain possible
Pain level when anesthesia is appliedImmediately after the procedurePain will be graded according to visual analogue scale, 0 meaning no pain, 10 meaning the worse pain possible
Time to sart of the action of the blockImmediately after the procedureTime from the procedure till the pain is reduced, in minutes

Countries

Croatia

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026